Researches

South Egypt Cancer Institute

Assiut University

# Title Department Research Member Research Year
31 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Department of Medical Oncology Prof. Ashraf Zeidan Abdalla Ahmed 2023
32 Value of FoxO3a Gene Expression in Pediatric Acute Lymphoblastic Leukemia Department of Clinical Pathology Dr. Doaa Fathi Hagag Ahmed 2023
33 Value of FoxO3a Gene Expression in Pediatric Acute Lymphoblastic Leukemia Department of Clinical Pathology Madonna Refaat Ayoub 2023
34 CD44 as a prognostic marker in early colorectal cancer: single center experience “South Egypt cancer institute”, Egypt Department of Medical Oncology Amany Nasr Ahmed Mohammed Elemary 2023
35 Could Local Surgery Improve Survival in Stage IV Breast Cancer? Department of Surgical Oncology Abdelrahman Kamel Fathy Mohammed 2023
36 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Department of Medical Oncology Dr. Amen Hamdy Zaki Ali 2023
37 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Department of Medical Oncology Amany Mohammed Abdel Moatamed 2023
38 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Department of Medical Oncology Dr. Salah Mabrouk Khallaf Abd Rabou 2023
39 Neutropenic Fever in Pediatric Patients with Cancer in South Egypt: A Report from a Single Institute Department of Pediatric Oncology Prof. Heba Abdel-Razik Sayed Hussein 2022
40 Pattern and Outcome of Neurological Complications During the Treatment of Pediatric Acute Leukemias in Upper Egypt Department of Pediatric Oncology Dr. Azaa Shibl Sayed Mahmoud 2022